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ABSTRACT!
Intellectual disability (ID) is a complex disease of the central nervous system (CNS). 
The genetic contribution to the etiology of ID is well established and, among the 
genetic conditions, the most frequent are the X-linked intellectual disability (XLID) 
forms. Among the XLID genes, Oligophrenin-1 (OPHN-1) encodes a synaptic Rho 
GTPase- activating protein that regulates neuronal morphology, proliferation and 
maturation. The involvement of OPHN-1 in XLID was well established by the 
identification of mutations within the gene, in patients with XLID. OPHN-1 gene is 
expressed in brain areas that are characterized by high synaptic plasticity: in 
particular, the olfactory bulb and the hippocampus. However, it is not clear how 
mutations in OPHN1 result in impaired neuronal development and consequent 
cognitive deficits.!
To address these issues, I have used a mouse model of XLID based on germline 
deletion of the OPHN1 gene (OPHN1 KO; Khelfaoui et al., J Neurosci 2007). In 
particular, as adult hippocampal neurogenesis recapitulates the processes of neuronal 
differentiation, I have studied the development of newborn cells in the hippocampus 
of wt and OPHN1 KO mice. Using labelling of newborn cells with the thymidine 
analogue bromo-deoxy-uridine (BrdU), I found that cell proliferation in the 
subgranular zone of the hippocampus was not impacted by OPHN1 deficiency. 
Importantly, reduced numbers of BrdU-positive neurons were found 50 days after 
BrdU pulse labelling in OPHN1 KO mice, indicating impaired neuronal 
differentiation. In keeping with these data, the number of migrating neuroblasts 
(stained with a doublecortin – Dcx -antibody) was also decreased in the dentate 
gyrus of KO animals. We also found reduced numbers of cells double positive for 
Dcx and the neuronal marker NeuN, confirming the impaired integration of newborn 
neurons in the hippocampus of OPHN1 KO mice.!
Prompted by these results, we tested a novel therapeutic strategy based on inhibition 
of the RhoA pathway, whose activity is potently stimulated by loss of OPHN-1. In 
particular, we administered via the drinking water fasudil, an inhibitor of the ROCK 
kinase. Preliminary data indicate that fasudil treatment restores normal numbers of 
Dcx-NeuN double positive cells in the hippocampus of OPHN1 KO animals. !
Altogether, these data demonstrate robust alterations in hippocampal neurogenesis 
in OPHN1 mice, and suggest a possible strategy for counteracting defects in neuronal 
differentiation triggered by loss of OPHN1. !!
 5
!
1- INTRODUCTION!
!
1.1 INTELLECTUAL DISABILITY!
!!
1.1.1 DEFINITION!
!
According to the tenth revision of the WHO, the Intellectual Disability (ID) “is a 
disorder defined by the presence of incomplete or arrested mental development, 
principally characterized by the deterioration of concrete functions at each stage of 
development and that contribute to the overall level of intelligence, such as cognitive, 
language, motor and socialization of functions; in this anomaly, adaptation to the 
environment is always affected. For ID, scores of intellectual development levels 
must be determined based on all of the available information, including clinical 
signs, adaptive behavior in the cultural medium of the individual and psychological 
findings” .!
On the other hand, the American Association on Intellectual and Developmental 
Disabilities (AAIDD) indicates that in addition to a significantly sub-average 
intellectual functioning, concomitant limitations are observed in two or more areas of 
adaptive skills, such as communication, home life and personal care; also, it’s been 
observed that the disorder presents itself before the age of 18.!
Altogether, ID is a pathological condition defined by cognitive and adaptive 
impairment, the latter expressed as social and practical skills. According to the 
AAIDD, there are five dimensions which define the ID:!
• Intellectual aptitudes!
• Adaptation level!
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• Participation, interaction and social roles!
• Health!
• Social context!
!
1.1.2 CAUSES!
!
The factors which have been related to induce ID are classified as: genetic, acquired 
( congenital and developmental) environmental and sociocultural.!
• Genetic factors!
Patients with Down Syndrome are the greatest group suffering from ID. Other less 
frequent genetic abnormalities are: Rett syndrome, fragile X syndrome and Will 
syndrome, among others.!
Moreover, there are some hereditary factors that can produce ID, like: galactosemy, 
Tay-Sachs disease, glycogen deposit disease and other related conditions.!
• Congenital factors!
These can be classified as: metabolic (neonatal hypothyroidism), toxic (such as lead 
poisoning, fetal alcohol syndrome, etc…) and infectious (like syphillis, 
toxoplasmosis, etc…)!
• Developmental factors!
These factors can come into play during the prenatal, perinatal and postnatal period: 
complications related with the pregnancy, the birth and the first moments of life 
could cause the onset of the ID.!
• Environmental and sociocultural factors " " !667
Different studies analyzed the correlation between socioeconomic poverty and ID. In 
particular, the insurgence of ID may be related to: scarcity of prenatal, perinatal and 
postnatal health care, adolescence care and family instability, inadequate health 
treatment and low level of stimulation, in addition to infant mistreatment (Katz G. et 
alia, Salud publica de Mexico 2008)!
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1.1.3 CLASSIFICATION!
!
Cognitive disabilities  has a common denominator: a subnormal intellectual 
functioning level; however, the extent to which an individual is unable to face the 
requirements established by society are been divided into four degrees of severity: 
mild (IQ between 50 and 69), moderate (IQ between 35 and 49), severe (IQ between 
20 and 34) and profound(IQ lower than 20). The characteristics of individuals must 
be found to define intervention guidelines and to promote a valid therapy (fig.1) 
(Katz G. et alia, Salud publica de Mexico 2008).!
Fig.1: Criteria to classify ID, based on the age of patients (Reproduced from: Gregorio Katz, Salud publica de 
Mexico, vol.50, supplement 2)!!
1.1.4 DIAGNOSIS!
!
To treat efficaciously the Intellectual Disability, it’s necessary to diagnosis it as soon 
as possible; however,  the lack of legislation in developing countries, the stigmata 
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and discrimination imposed by society and structure capable of diagnose the 
pathology, delays significantly the possibilities for interventions.!
A complete anamnesis, of course, is the first step to follow, especially during 
prenatal, perinatal and postanatal period, including a study of the genealogical tree 
for at least three generations and a deepen search for family antecedents. In second 
place, a physical exam is required, focusing on genetic abnormalities and 
malformations, followed by behavioral and neurological evaluations: if a clinical case 
is discovered, it’s necessary to perform specific analysis. However, if the clinical 
diagnosis is not established, cytogenetic evaluations, besides metabolic analyses, are 
needed: one of the most useful is the Fluorescence in situ hybridization (FISH), a 
technique which permits to analyze the entire subtelomeric region. If any result is not 
find yet, submicroscopic chromosomal disorders are evaluated.!
The use of Neuroimaging techniques (such as magnetic resonance imaging) is also 
critical to detect abnormalities in the anatomical structure of the brain. !
Metabolic analyses include: urinary tests for amino acids, organic acids, 
oligosaccharides, mucopolisaccharides and uric acid; in addition, sometimes it may 
be useful to study disorders of glycosilation or problems in the distal cholesterol 
pathways (Katz G. et alia, Salud publica de Mexico 2008).!
!
1.1.5 X-LINKED INTELLECTUAL DISABILITY!
!
Ten percent of cases of ID in boys are caused by genes located on the X chromosome: 
these are defined as the X-linked Intellectual Disabilities (XLID). Usually, in this type 
of syndromes, hemizygous boys are affected, while heterozygous girls are 
asymptomatic or have milder symptoms (due to the presence of a normal allele on 
one of the two X chromosomes). However, girls can be affected in two ways: the first 
one, involving X-linked dominant diseases, like Rett syndrome; the second one, in 
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which the girls are symptomatic, because the X chromosome that carries the 
mutation is not well inactivated.!
Thanks to the increase and development of more sophisticated techniques to 
diagnose and analyze the major characteristics of these pathologies, it’s been found 
out that dozens of genes are involved; in particular, microdeletion or X/autosome 
traslocation are been used for the characterization. Traditionally, the patients 
presenting the symptoms have been divided into two major groups (Vincente des 
Portes, Handbook of clinical neurology, 3rd series): !
!
• Syndromic XLID, which are recognizable thanks to some clinical signs, such as brain 
malformation or extraneurological problems; !
• “Nonspecific” XLID, the most frequent group, which cannot be determined on well-
defined clinical grounds.!
!
1.1.6 FRAGILE X SYNDROME!
!
Fragile X syndrome is the second major cause of ID after Down syndrome. Lubs, in 
1969, discovered that, in this kind of syndrome, there is a chromosomal break in the 
Xq27.3 region in chromosome X: thus, the origin of the name. From 1991, thanks to 
J.L. Mandel’s team, it’s been discovered the molecular mechanism of fragile X. It 
consists of a dynamic mutation with a CGG triplet amplification which takes place in 
two steps along generations: upstream of the promotor region of the FMRI gene, 
repeat sequences (CGG triplets) comprise less than 55 repeats in the general 
population. Generally, a grandfather or a grandmother carries a premutation, that is, 
between 55 and 200 CGG repeats, which is responsible for instability of this structure. 
Usually, if carried by female, the premutation tends to amplify; instead, if it’s carried 
by males, it is transmitted to all daughters, who could transmit it to 50% of their 
children, as pre- or complete mutation (>200 CGG). The above mentioned complete 
mutation causes a methylation of Fragile Mental Retardation 1 (FMR1) gene, which 
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blocks its expression: thus, the lack of FMR protein is the main cause of the 
symptoms of Fragile X syndrome. The gold standard to individuate the methylation 
of FMR1 remains the southern blot technique (Vincente des Portes, Handbook of 
clinical neurology 3rd series).!
!
!
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1.2 ROLE OF OLIGOPHRENIN-1 GENE IN INTELLECTUAL DISABILITY!
!!
1.2.1 The Rho GTPases signaling!
!
Because learning deficiency is a constant feature of ID patients, it’s been conjectured 
that this trait is due to a synaptic alteration: in first place, there are been evidences 
that ID related protein are enriched at pre- and/or post-synaptic compartments 
(Humeau Y. et alia, J. Neurochem. 2009); second, in ID patients, there are alterations 
concerning dendritic spines, actin-rich structures on which most excitatory synapses 
are located. Third, functional evidence has been provided for alterations in synaptic 
strength in models of ID (A. Pavlowsky et alia, Mol. Psychiatry, 2012). !
However, not much is known about the gene alterations implicated in intellectual 
impairment. Because of the involvement of the dendritic spines, recently, the family 
of Rho GTPases family has received much attention, due to their role in regulating 
actin dynamics and organization (N. Nadif Kasri et alia, Eur. J. Physiol. 2012).!
Rho family GTPases belongs to the Ras superfamily of small protein (about 21 KDa) 
GTPases. They have been divided into 8 different subgroups: Rho, Rac, Cdc42, RhoD, 
Rnd, RhoH/TTF, RhoBTB, Miro (P. Aspenström et alia, Biochem. J. 2004). Rho proteins 
are guanine nucleotide binding proteins, which act as molecular switches that cycle 
between an active GTP-bound form and an inactive GDP-bound form; moreover, 
their activity is spatiotemporally regulated by positive regulator guanine nucleotide 
exchange factors (GEFs) and negative regulators GTPases activating proteins (GAPs), 
and guanine nucleotide dissociation inhibitors (GDIs) (fig.2). !
!
!
!
!
!
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!
In particular, it’s been demonstrated that Rac1, Cdc42 and RhoA have a major role in 
controlling the changes in actin cytoskeleton in neurons (E.-E. Govek et alia, Dev. 
Neurobiol. 2011):  indeed, at the synapses, they are key regulators of formation and 
morphogenesis of spines, and are also implicated in synaptic plasticity (S.E. Newey 
et alia, J. Neurobiol. 2005). Specifically, Rac1 and Cdc42 have been shown to promote 
the formation, growth and maintenance of spines, whereas RhoA induces spine 
retraction and loss. The changes in morphology of dendritic spines are associated 
with Long-term potentiation (LTP) and long-term depression (LTD), two processes 
needed to remodel the synapse strength depending on their activity and which are 
believed to be the  cellular basis of memory and learning. Indeed, to produce stable 
LTP and LTD, enduring actin-dependent structural changes in spine heads are 
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Fig. 2- Overview of ID genes and their role in Rho-GTPase signaling at the synapse. On the left 
an excitatory synapse and, on the right, an inhibitory one. The yellow squares represent the 
Rho-GTPases, the red ovals are GAP proteins, while green ovals are GEF proteins; finally, ID 
genes are written in red. When activated, Rac1, Cdc42 and RhoA interact with downstream 
effector proteins, which, eventually, results in actin remodeling. (Reproduce from Wei Ba et alia, 
Exper. Cell Resea. 2014)
required. These changes are majorly linked with incorporation (LTP) or removal 
(LTD) of synaptic α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor 
(AMPARs) (L.a Cingolani et alia, Nat. Rev. Neuro. 2008): indeed, inhibition of actin 
polymerization attenuates LTP maintenance, whereas LTD is associated with filament 
disassembly (N. Honkura, Neuron, 2008). !
!
1.2.2 THE OLIGOPHRENIN-1 GENE!
!
Oligophrenin-1 (Ophn-1) gene is a gene located in X chromosome, in the q12 band. It 
is the first identified Rho-linked ID gene, characterized by 21 exons: it is ubiquitously 
expressed in the developing and adult brain. !
The Ophn-1 protein, is a RhoGAP, specifically stimulates GTP hydrolysis of members 
of the Rho subfamily, thereby negatively regulating Rho-GTPase activity; moreover, 
its central GAP domain inhibits RhoA, Rac and Cdc42 without any specificity (Govek 
et alia, Nature Neuro. 2004). Its N-terminal end contains a BAR (Bin, amphyphysin, 
RSV) domain, which binds endophilin, amphyphysin  and Cin85, thereby controlling 
clathrin-mediated endocytosis (CME), through the RhoA/Rho-associated protein 
kinase (ROCK) pathway. Beyond that, a pleckstrin homology (PH) domain follows, 
which should confer to OPHN-1 some specificity to the membrane binding, through 
the interaction with phosphoinositides. Finally, the C-terminal domain contains three 
proline rich regions at amino-acid positions 575, 629 and 740 with multiple Src 
homology 2 (SH3) binding domains (Khelfaoui K., Hum. Molec. Genet. 2009).!
The protein is abundantly expressed in all brain regions, including cortex and 
hippocampus. It is present in axons, dendrites and spines (E.-E. Goveck, Nat. 
Neurosci. 2004); at the synapse, it must be noted that Ophn-1 is present both in 
presynaptic and in postsynaptic regions of excitatory and inhibitory synapses. 
Finally, Ophn-1 is present in glia cells, where is colocalized with F-actin, because of 
its role in active membrane movements.!
!
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1.2.3 LOSS OF FUNCTION OF OPHN-1!
!
At present there is only a partial understanding of the cellular mechanisms in which 
Ophn-1 is implicated. However, several evidences indicate that loss of Ophn-1 
function leads to synaptic impairments, that could contribute to ID.!
From a molecular point of view, constitutive loss of Ophn-1 leads to abnormally high 
level of PKA activity and to the uncoupling of the cAMP/PKA signaling pathway 
from synaptic function and plasticity. Specifically, it has been observed that 
presynaptic PKA-dependent long term plasticity in both amygdala and hippocampus 
was severely compromised by absence of Ophn-1 (Khelfaoui M. et alia, Phil. Trans. R. 
Soc. 2014). Because of cAMP/PKA signaling role in learning and memory processes, 
dysregulation of this pathway following loss of Ophn-1 may result in learning 
deficits ( Selcher JC et alia, Neuroscientist, 2002). Moreover, it has been demonstrated 
that the loss of function of Ophn-1 leads to an hyperactivation of the RhoA/Rock 
pathway, responsible for receptors endocytosis through endophilin phosphorylation 
and interaction with CIN85.!
In hippocampal slice preparations, acute downregulation of Ophn-1 expression 
(using siRNA approaches) leads to alterations in the density and morphology of 
postsynaptic spine densities, along with changes in AMPARs and NMDARs mobility 
and postsynaptic LTP (Kasri N.N. et alia, Genes Dev. 2009). These effects are 
dependent on interaction of Ophn-1 with Homer 1b/c, a scaffolding protein involved 
in the organization of postsynaptic glutamate freceptors. Conversely, overexpressing 
Ophn-1 selectively enhanced AMPAR-mediated synaptic transmission and increased 
spine density (Kasri N. N. et alia, Genes Dev. 2009). Finally, Ophn-1 is also implicated 
in inhibitory synaptic transmission: indeed, impairments in presynaptic vesicle 
recycling and a reduction in the readily releasable pool were recently observed in 
inhibitory synapses in Dentate Gyrus (DG) of Ophn-1 KO mice (A.D. Powell et alia, J. 
Physiology, 2012).!
!
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1.2.4 OPHN-1 ID- RELATED PHENOTYPE!
!
The human phenotype of ID caused by Ophn-1 mutations was linked, initially, with a 
non-syndromic form of XLID. However, it was later demonstrated that the loss of 
Ophn-1 induced a precise clinical case of ID. Generally, the boys affected by this 
syndrome presented, as a consistent feature, epileptic seizures, manifested as 
myoclonic events associated with absences and tonic-clonic fits. Furthermore, these 
patients showed micropenis and small testes without hormonal imbalance: this 
character has been linked with some neuron migration defects (Pradham M. et alia, 
Am. J. Med. Genet. 1999). Cartsen Bergmann and colleagues (Brain, 2003) analyzed 
also the neuro-morphological consequences of loss of Ophn-1 in male patients with 
ID. The neuroradiological examination showed a frontally and temporally pronunced 
reduction in cerebral volume with a widened interhemispheric fissure. Beside that, 
also the lateral and third ventricle presented an increase of volume, while the fourth 
ventricle appeared normal. There was lower vermian agenesis and bilateral 
cerebellar hypoplasia with asymmetric involvement. !
Female carriers seem to be hardly detectable at the clinical levelsince strabismus 
represented the only consistent character. Other possible features are: impairment in 
verbal skills and moderate kinetic deficits, probably due to a skewed X-inactivation 
(Bergmann C. et alia, Brain, 2003).!
!
!
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1.3 THE MOUSE MODEL OF X-LINKED ID!
!
1.3.1 GENERATION OF OPHN-1 KNOCK-OUT MOUSE!
!
To observe and study the pathophysiology of Ophn-1-related ID, Malik Khelfaoui 
and his coworkers have created a mouse model in which they inactivated the Ophn-1 
gene. !
In order to do this, they disrupted the open reading frame of the Ophn-1 gene by the 
insertion of 100 bp in the coding sequence of exon 9, which leads to premature stop 
codon after the BAR domain ( amino acids 1- 242) and before the GAP domain. !
The exon 9 was targeted by homologous recombination leading to the insertion of a 
phosphoglycerolkinase-hygromycin resistant gene cassette (Hygro) flanked with 
LoxP sites. The Cre recombinase catalyzed the deletion of sequences between LoxP 
sites and led to the removal of the selective cassette in the final Ophn-1 mutated 
allele. Therefore, they created chimeric mice, by aggregation into a C57BL/6 
blastocyst. The male chimeras, then, were crossed to C57BL/6 females from a 
transgenic  line expressing the Cre recombinase early in development to generate N1 
heterozygous females with a pure mutant allele deleted of the pgk-hygromycin-
resistan gene cassette. The residual 100bpsequence consists of one remaining LoxP 
site after excision by the Cre recombinase plus adjacent polylinker sequence from the 
targeting vector (fig.3)( Khelfaoui M. et alia, J. Neurosci. 2007).!
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Fig. 3: Scheme that represent the inactivation of 
Ophn-1 gene (Reproduce from Khelfaoui et alia, 
J. Neurosci. 2007)
1.3.2 BEHAVIORAL, SOCIAL AND COGNITIVE IMPAIRMENTS!
!
The generated strain was analyzed from a behavioral, social and cognitive point of 
view. No great differences were observed between mutant males and their wild-type 
(WT) in any anxiety-related variables as tested in the elevated O-maze and the light-
dark box. However, the mutant males presented higher exploration scores in the 
center of the open field compared with control animals, suggesting that they were 
less anxious. !
Moreover, the KO mice showed a less aggressive behavior than WT mice, as seen by 
introducing an intruder in their cage.!
To study their capacity of learning and memorization, the Morris water maze test 
was used. This is a classical hippocampus-dependent task of spatial learning and 
memory, in which mice rely on spatial cues to navigate from start locations around 
the perimeter of an circular swimming pool to locate a submerged escape platform. 
The authors showed that Ophn1-/y spent less time floating compared with Ophn1+/y ; 
moreover, the KO mice showed no preferences for the target quadrant during the 
probe trial, indicating a spatial memory impairment (Khelfaoui M., J. Neurosci. 2007).!
!
1.3.3 NEURANATOMY OF OPHN1-/Y MICE!
!
For what concerns the anatomy of the Ophn-1 KO mouse brain, the main character of 
these animals was the enlargement of lateral and third ventricles, shown in 70% of 
Ophn1-/y , whereas this phenotype was detected only in 10% of Ophn1+/y mice. Because 
it’s been observed that this enlargement was rather mild during the weaning period, 
this phenotype likely worsens with age. However, KO mice showed no other 
significant neuroanatomical deficit at the macroscopic level. However, studying the 
fine structure of neurons in hippocampus and cortex, it’s been found that the main 
changes were involving the dendrite spines in both regions, indicating that, in KO 
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mice, the loss of function of Ophn-1 leads to immaturity of dendritic spine in adult 
hippocampus, compared with WT animals (fig.4) (Khelfaoui M., J. Neurosci. 2007).           !
                                                                                     !
1.3.4 RESCUE OF THE PHENOTYPE !
!
These data described above make clear that the ID caused by loss of function of 
Ophn-1 gene is a complex syndrome, in which many neuronal processes are 
impaired, and not all the molecular, cellular and synaptic mechanisms are presently 
known. However, it’s been demonstrated that is possible to act on different pathways 
in order to restore the physiological function of CNS in ID patients. One of this 
strategy imply the use of inhibitors of the Rho Kinase (ROCK). Rock is one of the best 
known downstream target of RhoA and is a member of the ACG kinase family, which 
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Fig.4: Reduced apical spine density and basal spine lenght in KO and WT mice CA1 
hippocampal neurons. It’s possible to see the decreased spine density in KO mice. (Reproduced 
from Khelfaoui et alia, J. Neurosci. 2007)
is a group of kinases with a highly conserved amino acid sequence in the kinase 
domain. ROCKs have three distinct major domains, an RBD located in the coiled coil 
region, a catalytic kinase domain and a cystein-rich domain (Schmandke A. et alia, 
Neuroscientist 2007).!
In the ROCK inactive state, the C-terminus acts as an autoinhibitory loop by folding 
back onto the kinase domain. This inactive state is reversed when the active Rho-GTP 
binds to the RBD breaking off the inhibitory loop. Once ROCK is biochemically 
active, it can phosphorylate many target proteins/substrates such as myosin light 
chain, LIM kinase, intermediate filaments, microtubule-associated proteins and 
collapsin response mediator protein: these substrates are highly involved in 
cytoskeletal re-arrangements, contractility, neuronal development, etc. (Mueller, Nat. 
Rev. Drug Discov. 2005) (fig.5).!
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Fig. 5: The ROCK signaling pathways and their downstream targets and their affected biological processes.  On 
the left, it’s represented one of its inhibitors, Fasudil.(Reproduced from Mohamad R. et alia, Electrophor. 2012)
As shown by Khelfaoui and colleagues, one of the most prominent inhibitors of 
ROCK is Fasudil, an isoquinoline derivative drug approved for clinical trials in 
United States (Bowerman, BMC Med. 2012). Its structure can be seen below: !
Fasudil has a structure containing isoquinolines and a homopiperazine ring, 
connected by a sulfonyl group. Fasudil acts on ROCKs by binding to a hydrofobic 
cleft between the N- and C- terminal lobes of the kinase domain of ROCK through 
the insertion of the planar isoquinoline ring of fasudil into the adenine binding 
pocket of protein kinases. Fasudil’s homopiperazine ring is situated at the door of the 
cleft where the active residues are clustered (Yamaguchi, Structure, 2006). Khelfaoui 
and his coworkers (Hum. Molec. Genetic, 2009) used administration of Fasudil in the 
drinking water in their mouse model of Ophn-1-related ID and showed that Ophn1-/
y mice restored internalization rate of AMPARs, specifically the GLUR1 subunit, 
rescuing the N-metyl-D-aspartic acid (NMDA)-dependent LTD, reactivating synaptic 
plasticity and transmission in KO mice hippocampal neurons. !
Prompted by these observations, we decided to investigate whether the process of 
neurogenesis in adult mammalian brain was affected by the loss of function of 
Ophn-1 in mice, and whether treatment with fasudil could rescue the pathological 
phenotypes.!
!
!
!
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1.4 NEUROGENESIS IN ADULT MAMMALIAN BRAIN!
!!
1.4.1 DEFINITION!
!
Neurogenesis is the process of generating functional neurons from precursor cells. 
This process was traditionally viewed to occur only during embryonic and perinatal 
stages in mammals. However, Altman’s studies provided the first anatomical 
evidence for the presence of newly generated dentate granule cells in the postnatal 
rat hippocampus (Altman J. and Das G.D., J. Comp. Neurol. 1965). The field of adult 
neurogenesis took off after the introduction of bromo-deoxyuridine (BrdU), a 
nucleotide analog, as a lineage tracer (Khun H.G. et alia, J. Neurosci. 1996) and 
demonstrations of life-long continuous neurogenesis in almost all mammals 
examined, even humans (Eriksson P.S. et alia, Nat. Med. 1998). Active adult 
neurogenesis is spatially restricted, under normal conditions, to two specific brain 
regions: the subgranular zone (SGZ) in the dentate gyrus (DG) of hippocampus, 
where new dentate granule cells are generated, and the subventricular zone (SVZ) of 
the lateral ventricles, where new neurons are generated and, then, migrate through 
the rostral migratory stream (RMS) to the olfactory bulb, to become interneurons 
(Gage F.H. Science 2000). In this thesis, I focused on the SGZ of the DG of 
hippocampus, in which the population of stem cells is called Radial Glia cells 
(RGCs), expressing glial fibrillary acidic protein (GFAP).!
!
1.4.2 ORIGIN OF THE SGZ IN THE DG!
!
The DG of hippocampus originates from the dorsal neuroepithelium of the cortical 
hem, from a ventricular indentation called the dentate notch, where the first 
proliferative zone, called the primary matrix of the DG, locates (Altman J. et alia, J. 
Comp. Neurol. 1990). Next, the progenitor cell pool expands, forming the secondary 
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matrix and the first granule cells are generated (Altman J. et alia, J. Comp. Neurol. 
1990). Thus, the first wave of granule cells originates from the progenitors located at 
the lateral margin of the hippocampal primordium, around embryonic day 14 (E14) 
in mice. With the formation of the dentate primordium, the progenitors are found 
along the ventricular germinal zone, in the dentate notch and the fimbrodentate 
junction (E15 in mice). These progenitors form the primordial radial glia scaffold and 
extend their cytoplasm as a single process from the germinal zone to the pial surface 
and are thus denominated radial glia cells. Next, the newborn granule cells migrate 
along this radial scaffold into the incipient DG (Rickmann et alia, J. Comp. Neurol. 
1987). Later, during the first days after birth, a secondary radial glia scaffold develops 
after significant anatomical changes. The orientation of the radial processes shifts and 
the main proliferative area locates into the dentate gyrus, in the hilar zone beneath 
the forming blades of the granule cells layer, forming the tertiary matrix (Rickmann 
et alia, J. Comp. Neurol. 1987). Later on, around postnatal day 15 (P15), proliferation is 
mostly absent from the hilar region and remains only in the SGZ, where the somata 
of the RGCs, forming the secondary radial glia scaffold are located. This secondary 
radial glia scaffold is fully developed by the second postnatal week in mice, and than 
regresses: its size decreases and the radial process retracts and arborizes in the 
molecular layer (Brunne B. et alia, Glia 2010). By P21, the development of the DG is 
considered complete; however, the population of radial glia responsible for adult 
neurogenesis remains in the SGZ, maintaining the same morphological and marker-
expression characteristics as during development. A population of non-radial/
horizontal population of neural stem cells (nr/hNSC) has been suggested to exist in 
adult DG: these cells would be capable to generate radial neural stem cells, astrocytes 
and neurons, however, their characteristics, properties and origin are still poorly 
defined (Encinas J.M. et alia, Int. J. Devl. Neurosci. 2013).!
!
!
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1.4.3 DEVELOPMENT OF NEURAL STEM CELLS IN ADULT DG!
!
Adult neurogenesis recapitulates the complete process of neuronal develoment in 
embryonic stages. In the adult SGZ, proliferating radial and non radial precursors 
give rise to intermediate progenitors, which in turn generate neuroblasts which 
migrate into the DG (Ge S. et alia, Nature, 2006). After a prolonged maturation phase, 
adult-born neurons exhibit similar basic electrophysiological properties as mature 
neurons, such as firing behavior and the amplitude and kinetics of GABAergic and 
glutamatergic inputs (Mongiat L.A. et alia, Eur. J. Neurosci. 2011).  There are some 
principles that emerged from the study adult neurogenesis. First, the most important 
milestones of neuronal development are conserved among embryonic, postnatal and 
adult neurogenesis: during the embryonal period, immature neurons receive 
GABAergic synaptic inputs before the formation of glutamatergic inputs and are 
depolarized by GABA, due to high expression levels of the chloride importer NKCC1 
(Ge S. et alia, Nature, 2006). One notable difference is a significantly slower timing of 
neuronal maturation in adult, compared to embryonic development (Duan X. et alia, 
Cell 2007). Second, neural progeny survival exhibits two critical periods: one at the 
intermediate progenitor and neuroblast stage (Platel J.C et alia, Neuron 2010) and one 
at the immature neuron integration stage (Mouret A. et alia, J. Neurosci. 2008). 
Newborn neurons also exhibit enhanced synaptic plasticity of their glutamatergic 
inputs within a critical period. Therefore, it’s been suggested that such enhanced 
plasticity may give adult-born neurons an advantage in the competition with mature 
neurons for selective formation and stabilization of afferent and efferent synaptic 
connections (Tashiro A. et alia, Nature 2006) (fig.6).!
Such properties may also allow integrated adult-born neuron to make a unique 
contribution to information processing during this period.!
!!!
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!!!
1.4.4 REGULATION OF ADULT NEUROGENESIS!
!
1.4.4.1 NEUROGENIC NICHE IN THE ADULT BRAIN!
!
Both intrinsic and extrinsic mechanisms regulate different aspects of adult 
neurogenesis. For a better understanding of these processes, it’s necessary to define 
the concept of “niche”. Niche, as suggested by Schonfield (Schonfield R., Blood Cells, 
1978), is the microenvironment that anatomically houses stem cells and functionally 
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Fig. 6: Summary of  five developmental stages during adult hippocampal neurogenesis: (1) activation of 
quiescent radial glia-like cell in the SGZ; (2) proliferation of non radial precursor and intermediate 
progenitors; (3) generation of neuroblasts; (4) integration of immature neurons and (5) maturation of adult-
born dentate granule cells. ML: Molecular Layer; GCL: Granule Cell Layer; SGZ: Subgranular Zone 
(Reproduced from Ming G.-Li et alia, Neuron 2011).
controls their development in vivo. In this specific case, the niches in which we can 
identify neurogenetic processes are the SGZ and SVZ. Endothelial cells, astrocytes, 
ependimal cells, microglia, mature neurons and progeny of adult neural precursors 
are among major cellular components of the adult neurogenic niche. Vascular cells 
play an important role in regulating proliferation of adult neural precursors: it’s been 
discovered, indeed, that in SGZ, dense clusters of dividing cells were found to be 
anatomically close to the vasculature, especially capillaries.!
Moreover, astrocytes form gap junctions and are closely associated with the 
vasculature and its basal lamina in the adult SGZ, likely modulating the influence of 
endothelial and circulation derived factors as well as the availability of cytokine and 
growth factors in the basal lamina. Microglia has, also, shown a prominent role in 
regulating adult neurogenesis. Under basal conditions, apoptotic corpses of newly 
generated neurons are rapidly phagocytosed from the niche by unactivated microglia 
in adult SGZ. Under inflammatory conditions, reactivated microglia can have both 
beneficial and damaging effects on different aspects of adult neurogenesis, 
depending on the balance between secreted molecules with pro- and anti-
inflammatory action (Ming G.-L. et alia, Neuron 2011).!
Moreover, it’s been suggested that newborn cells progeny can regulate the behavior 
of neural precursors. In the SGZ, quiescent radial glia-like cells are rapidly activated 
to support continuous neurogenesis after eliminating rapidly proliferating progeny 
with AraC® (Cytarabine) treatment. In the SGZ, local interneurons release GABA, 
which in turn regulates cell proliferation as well as maturation, dendritic 
development and synaptic integration of new born neurons. On the other hand, 
glutamate regulates survival of newborn neurons, through an NMDAR-dependent 
mechanism (Ming G.-L. et alia, Neuron 2011).!
!
!
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1.4.4.2 MOLECULAR REGULATION OF NEUROGENESIS!
!
A number of morphogenes, i.e., signaling molecules that acts directly on cells to 
produce specific cellular responses depending on their local concentration, serve as 
niche signals to regulate maintenance, activation and fate choice of adult neural 
precursors. Growth factors, neurotrophins, cytokines and hormones are major 
regulators of adult neurogenesis. Different phases of adult neurogenesis are subject 
to regulation by pharmacological manipulations, mostly through various 
neurotransmitters systems. The DG is enriched with inputs from many brain regions 
that release different neurotransmitters and neuropeptides. Among classic 
neurotransmitters, GABA, glutamate and acetylcholine directly regulates migration, 
maturation, integration and survival of newborn neurons, although it is not perfectly 
clear if pharmacological manipulations act by directly affecting neural precursor and 
newborn neurons, or through indirect modulation of the niche. In the DG, an 
important role is played by reelin. Reelin is a large secreted extracellular matrix 
glycoprotein that helps regulating processes of neuronal migration and positioning in 
the developing brain by controlling cell–cell interactions. Besides this important role 
in early development, reelin continues to work in the adult brain. It modulates 
synaptic plasticity by enhancing the induction and maintenance of long-term 
potentiation. It also stimulates dendrite and dendritic spine development and 
regulates the continuing migration of neuroblasts generated in adult neurogenesis. 
Specifically, reelin prevents new neurons from migrating into the hilus region (Ming 
G.-L. et alia, Neuron 2011).!
At the intracellular level, cell-cycle regulators , transcription factors and epigenetic 
factors are major intracellular regulators of adult neurogenesis. Cell-cycle inhibitors 
like p16, p21 and p53 play major roles in maintaining the quiescence of adult neural 
precursors; deletion of these factors, indeed, leads to transient activation and 
subsequent depletion of the precursor pool. Sequential development of different 
transcription factors ensures proper development of adult neural precursors. One of 
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this transcription factor is Sox2, which plays a role as major mediator of Notch 
signaling in maintaining the precursor pool in the adult SGZ. Moreover, various 
epigenetic mechanisms play important roles in fine tuning and coordinating gene 
expression during adult neurogenesis, including DNA methylation, histone 
modifications and non-coding RNAs (Sun B. et alia, Cell Stem Cell 2009).!
!
1.4.4.3 ENVIRONMENTAL REGULATION OF NEUROGENESIS!
!
One hallmark of adult neurogenesis is its sensitivity to physiological and 
pathological stimuli at almost every stage, from proliferation of neural precursors to 
development, maturation, integration and survival of newborn neurons. Among the 
physiological stimuli that enhanced neurogenesis, it’s been demonstrated that 
physical exercise promotes proliferation in SGZ, while an enriched environment 
promotes neuronal survival (Rossi D.J. et alia, Cell 2008). Also, it’s been seen that 
learning modulates adult neurogenesis (Zhao C. et alia, Cell, 2008); even seizures 
increase cell proliferation in SGZ, but also lead to mis-migration of newborn neurons 
to the hilus, aberrant dendritic growth, mossy fibers recurrent connections and 
altered electrophysiological properties of GABAergic and glutamatergic synaptic 
inputs for newborn cells. (Kron M.M. et alia, J. Neurosci. 2010). Another potent 
inducer of adult neurogenesis is focal or global ischemia: stroke induces cell 
proliferation and migration of newborn neurons to infarct sites, the vast majority of 
which fail to survive over the long term, presumably due to the lack of functional 
connections and trophic support (Arvidsson A. et alia, Nat. Med. 2002). Conversely, 
physiological stimuli that decrease neurogenesis are: chronic stress, which lead to 
decreased cell proliferation in the adult SGZ, whereas the effect of acute stress on cell 
proliferation and new neuron survival depends on paradigms of stress and species 
(Mirescu C. et alia, Hippocampus, 2006). Also diabetes impairs cell proliferation in the 
adult SGZ through a glucocorticoid-mediated mechanism (Sun B. et alia, Cell Stem 
Cell 2009). Another major negative regulator of adult neurogenesis is inflammation, 
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induced by injuries, degenerative neurological diseases and irradiation (Carpentier 
P.A. et alia, Neuron 2009). It’s clear, then, that the processes involved in neurogenesis 
are of very different types, but the better understanding of these mechanisms could 
lead to find new therapeutic strategies to enhance functional neurogenesis for 
regenerative medicine.!
!
!
1.4.5 STUDYING NEUROGENESIS IN ADULT DG OF HIPPOCAMPUS!
!
The current studies about neurogenesis have allowed to clarify in detail the series of 
steps by which neural stem cells and progenitors give rise to new neurons in the DG. 
However, the first true step ahead was done by Khun and his coworkers, who 
demonstrated that the thymidine analogue Bromo-deoxyuridine (BrdU) is a useful 
lineage tracer to investigate the state of proliferation in the DG of hippocampus 
(Khun H.G. et alia, J. Neurosci. 1996). Nowadays, the identification of the various 
subtype cells involved in neurogenesis can be performed employing different cellular 
markers, which permits to analyze the different stages of maturation of cells in DG.!
!
1.4.5.1 BRDU!
!
Two strategies can be used for examining cell proliferation: the first involves the 
treatment of the animals with a compound that labels mitotically active cells and 
later detecting the label; the second, instead, involves the detection of an endogenous 
protein that is only expressed in mitotically active cells. However, the downside of 
the first method is that it requires treatment who could lead to a potential alteration 
of proliferation. The downside of the second type of method, instead, is that it’s 
possible to see only proliferation at a one time point.!
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Currently, the gold standard for investigating the state of proliferation in DG is the 
use of BrdU, a thymidine analogue that is stably and specifically incorporated into 
the DNA in place of thymidine during the DNA synthesis S-phase of the cell cycle. 
DNA that has incorporated BrdU can be detected using standard 
immunohistochemical methods after denaturing the DNA. BrdU immunostaining in 
the adult brain is specific for dividing cells, even when the level of DNA repair is 
dramatically increased; moreover, it remains specific even when BrdU id given at 
high doses (Christie B.R. et alia, Hippocampus 2006). The only flew of BrdU, although 
it marks the mitotic active cells, is that it doesn’t tell anything about the cells which 
are stained. Fortunately, there are various markers that can give information about 
the phenotype of the cells that are labelled.  In this thesis, I focused especially on two 
of them, in addition to BrdU: Doublecortin (DCX), to study migrating neuroblasts, 
and Neuronal Nuclear antigen marker (NeuN), to identify the mature neurons. I also 
examined the status of inhibitory circuitry in the hilus using staining for 
Neuropeptide Y (NPY), which marks a subpopulation of GABAergic inhibitory 
interneurons.!
!
1.4.5.2 DOUBLECORTIN!
!
Doblecortin (Dcx) is a microtubule-associated protein: it is expressed by migrating 
neuroblasts (from about 4 days to about 28 days after cell birth). Though a 
microtubule-associated protein, it regulates filamentous actin structure in developing 
neurons, also regulating the microtubule of axonal growth cones. In the dentate 
gyrus of the developing hippocampus, Dcx is expressed in cells with begin their 
dendritic growth, but diminishes when the neurons mature. Dcx also promotes the 
migration of human progenitor cell-derived neurons in the DG. Dcx is expressed 
early in neuroepithelial cells from their first expression of neuronal lineage and 
during migration (Christie B.R. et alia, Hippocampus 2006).!
!
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1.4.5.3 NEURONAL NUCLEAR ANTIGEN!
!
NeuN is a low molecular weight (46-48 kDa) nucleoprotein. It’s recognized by a 
specific antibody and may be demonstrated immunohistochemically in most, but not 
all, neurons of the central and peripheral nervous system in humans. NeuN is now 
identified as Fox3, a new member of the Fox1 gene family and regulatory splicing 
factors. Glial and ependimal cells are non-reactive for NeuN. NeuN is a particularly 
valuable marker because of its late expression in neuronal maturation. In the 
hippocampus, both granule cells of the DG and pyramidal cells of Ammon’s horn are 
labeled by NeuN as they mature (Christie B.R. et alia, Hippocampus 2006).!
!
1.4.5.4 NEUROPEPTIDE Y!
!
Subgroups of hippocampal interneurons are characterized by the expression of NPY. 
NPY is a 36-amino acid neuropeptide that acts as a neurotransmitter in the brain and 
in the autonomic nervous system of humans: it is contained in at least four types of 
GABAergic interneurons in the dentate gyrus, many of which also contain 
somatostatin, and give rise to the dense NPY innervation of the dentate outer 
molecular layer. Y1 and Y2 receptors are the most abundant NPY receptors expressed 
in the dentate gyrus. Y1 receptors are postsynaptic receptors, primarily located on 
granule cell dendrites in the molecular layer and some interneurons, while Y2 
receptors are presynaptic receptors mediating inhibition of glutamate release, and 
potentially that of NPY and GABA depending on their presynaptic localization, and 
may also be expressed on some hilar interneurons (Sarnat H.B., Clin. Neuropath. 
2013). !
!
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Fig. 7: Scheme of adult neurogenesis in the hippocampal DG. (A) During the mitotic phase, two types of 
progenitors proliferate in the subgranular zone (SGZ) of the DG: radial glia-like progenitors (type I cells, 
expressing Nestin, GFAP and Sox2) and amplifying progenitors (type II cells, expressing Sox2 only). Before 
becoming post-mitotic, the progenitors undergo a short intermediate stage (neuroblasts) during which they 
become committed to the neuronal fate and begin expressing doublecortin (DCX). In the post-mitotic phase, 
DCX-positive newborn neurons derived from neuroblasts undergo morphological and physiological maturation 
with the final expression of the mature neuron marker, NeuN (Reproduce from: Gasparini L. et alia, ACNR 2013).!
1.5 AIM OF THE THESIS!
!
The goal of this thesis is to evaluate alterations in adult neurogenesis in a mouse 
model of ID characterized by loss of function of Ophn-1. XLID is a complex 
syndrome that implies genetic, metabolic and environmental factors, and there is 
currently no real cure for it. From a basic science point of view, the role of 
Oligophrenin-1 in the brain is not clear and it remains to be seen how mutations in 
Ophn-1 affect neuronal development and function and contribute to ID. In this 
context, adult hippocampal neurogenesis allows to study in detail different aspects of 
neuronal development, including proliferation, migration, elaboration of dendrites 
and axons, and integration into the neuronal network. All of these steps are essential 
for normal function of the newborn neurons. Indeed distortions in neural circuit 
formation are associated to altered information processing, which is likely to be 
responsible of the cognitive impairment present in ID.!
Understanding  the molecular mechanisms underpinning XLID is crucial to develop 
any future  therapeutic strategies. In particular, in this thesis I have tested a possible 
therapeutic strategy for rescuing specific deficits in adult neurogenesis, based on 
fasudil-mediated inhibition of ROCK signalling, a major pathway set in motion by 
loss of Ophn-1.!
!
!
!
!
!
!
!
!
!
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!
2 - MATERIALS AND METHODS!
!
2.1 ANIMALS AND EXPERIMENTAL PROTOCOL!
!
Every effort was made to minimize the number of animals and their suffering. The 
experimental design and all procedures were in accordance with the guidelines of 
Italian Ministry of Health for the care and use of laboratory animals. Ophn-1−/y mice 
and wild-type littermates were generated by breeding heterozygote females 
(Ophn-1+/−) with wild-type males (Ophn-1+/y), resulting in ∼50:50 !
Ophn-1+/y:Ophn-1−/y. Mice were housed in an animal room with a 12-hour/12 hour 
light/dark cycle, with food and water available ad libitum. A total of 20 male animals 
were used in the experiment. At post-natal day (p) 60, animals were divided into 
three experimental group: !
•  9 animals Ophn-1 +/y   wild type animals (Control Group)used as controls!
•  7 animals Ophn-1 -/y   without drug treatment (Sham Group)!
•  4 animals Ophn-1-/y  treated with fasudil (Rescue Group)!
The three groups of animals were housed in standard conditions as above; the Sham 
Group  was treated with Fasudil (0,64 mg/ml, in H2O) for 3 weeks in drinking water. 
The solution was renewed every week. Mice of Control Group and Sham group were 
given the same amount of water per animal and the average of water consumed was 
constantly monitored to ensure that the presence of the drug had no impact on water 
intake. In order to label newborn neurons in the Dentate Gyrus (DG) of the 
Hippocampus, all mice received, between p60 and p70, in one day, 4 intraperitoneal 
injections of Bromo-deoxyudridine (BrdU,50 mg/kg)  spaced by two hours. Mice 
were sacrificed by perfusion at 1 day (to assess proliferation), and 15 and 50 days 
after BrdU (to evaluate incorporation of new neurons in the adult DG). !
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2.2 GENOTYPING !
!
The genotype of mice was determined by PCR analysis on small samples of tail tissue 
taken from pups at P7. Samples were incubated overnight in 0.5 mL of Lysis Buffer 
and 4 %L of 20 mg/mL Proteinase K at 55 °C.!
Then, samples were centrifuged at 13000 rpm for 10 min to pellet undigested hair 
and obtain the supernatant. After that, 0.5 ml of isopropanol was added, inverting 
the tubes a few times to reveal the denatured DNA: so, samples were centrifuged at 
13000 rpm for 10 min at 4 °C. After eliminating the supernatant, pellets were washed 
with 200 %L of 70% ethanol; then, samples were centrifuged again at 12000 rpm for 5 
min at room temperature (RT). The DNA pellet was finally resuspended in 300 %L of 
TRIS-EDTA buffer (TE).!
The genotype of all 11 mice were revealed through PCR procedure: all samples of 
DNA (4 %L) were added with 1 %L of primers Forward (F; 5’-
G C C C A T G T T G T G A G C A G A G A A A T C ) a n d R e v e r s e ( R ; 5 ’ -
GGAAGCTAGAGGATGACCCTG) (Sigma Aldrich), 6.5 %L of distilled water (Sigma) 
and 12,5 %L of Ready Mix (Sigma) for a total volume of 25 %L, with the following 
protocol: !
• A first denaturation phase at 95 °C for 3 minutes.!
• 35 cycles of amplification, composed by 3 steps at 94 °C, 55 °C and 72 °C, 30 
seconds each.!
• A final step of incubation at 72 °C for 10 minutes!
After amplification, all samples were made run in agarose gel (1.5%), with 1:10.000 
Ethidium bromide(Sigma), in TRIS-Borate-EDTA buffer (TBE, Sigma) for 1h at 110 V 
in Biorad apparatus. !
Analysis of the results was performed using Chemidoc XRS System (Biorad), that 
allows to visualize the bands of our interest by UV illumination: !
• Ophn-1+/y animals have a 400 bp band!
• Ophn-1−/y animals have a 500 bp band!
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• Ophn-1+/− animals have both strips!
!
!
2.3 FIXATIVE PREPARATION!
!
Paraformaldehyde solution (4% in distilled water) was used to fix brain tissues. Stock 
solution at 8% was prepared by dissolving the opportune weight of 
paraformaldehyde powder in distilled water under a chemical hood. Solubilization 
was favored by heating the solution between 50 - 55 °C, while stirring. To end the 
procedure, solution were clarified by adding NaOH 10N (2.5 drops every 100 mL). 
The clarified solution was cooled at RT and preserved at 4 °C.!
The stock solution was, then, diluted at 4% with TBS at pH 7.4!
!
!
2.4 BRAIN PREPARATION!
!
Two weeks after BrdU injections, animals were sacrificed to extract brain tissues after 
intracardiac perfusion with Paraformaldehyde 4% solution. This process allows to fix 
brain tissues, preserving cells integrity and morphology by a prompt arrest of 
autolysis processes and the conferral of structural stability to the chemical 
components of the cytoplasm. Briefly,  mice were deeply anesthetized with overdose 
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of chloral hydrate (10.5%, in saline); the deep state of anesthesia was assessed by 
verifying the absence of reflexes after pinching the tail and the digit of the animal. 
Then, mice were positioned on a surgery table under chemical hood and a rapid 
thoracotomy was performed to expose the heart. !
After that, the decendent aorta was clamped with hemostatic pincers, to restrict 
passage of the fixative to the superior circulation. A sharpened needle was connected 
to a peristaltic pump, regulated on a flux speed of  40 mL/min, and inserted into the 
left ventricle to allow passage of the fixative. The right atrium was pinched to allow 
flowing out of the fixative solution.!
Before the fixative administration , blood vessels were washed with phosphate Buffer 
Saline (PBS, 0.1 M) until the all blood was completely removed. Finally, at least 50 mL 
of paraformaldehyde at 4% was administrated, permitting the fixation of tissues. At 
the end of the process, the skull was carefully opened to expose the whole dorsal face 
of the brain. After assessing the good result of the perfusion by evaluating the white 
aspect of tissues and the absence of clots, the entire brain was gently removed with a 
surgical spoon. Finally, isolated brains were post-fixed for 2 hr. Brains were frozen 
and coronal sections (40 microns) were cut using a freezing microtome. Sections were 
maintained in a serial order, and kept in PBS solution at 4°C.!
!
!
2.5 IMMUNOHISTOCHEMISTRY!
!
One of every six sections were selected to perform  immunohistochemical analysis.     !
For double immunostaining with Doublecortin (Dcx) and NeuN, free-floating 
sections were blocked for 1h at RT with 10% rabbit serum (RS), 0.3% Triton X-100 in 
PBS. Slices were, then, incubated overnight at 4 °C with anti-Dcx and anti-Neun 
primary antibodies (respectively goat polyclonal, 1:1000, Sigma and guinea pig, 
1:1000, Millipore) 2% RS and 0.2% Triton in PBS. The primary antibodies were 
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revealed by incubation for 2h at RT with secondary antibodies (respectively, donkey 
anti-goat Rodamine Red X (RRX), 1:200, Jackson and Donkey anti- guinea pig 
Alexafluor 488, 1:300, Jackson) diluted in 1% RS and 0.1% Triton in PBS.!
For BrdU staining, free-floating sections were initially treated for 30’ at 37 °C in HCl 2 
M to denature DNA. Then, sections were blocked for 30’ at RT with 10% normal goat 
serum (NGS), 0.3% Triton in PBS. Slices were incubated overnight at 4 °C with anti-
BrdU primary antibody (rat monoclonal, 1:200, Abcam), NGS 5%, Triton 0.1% in PBS. 
The primary antibody was revealed by incubation for 2h at RT with secondary 
antibody (Donkey anti rat Cy3, 1:500, Jackson), diluted in Triton 0.1% in PBS.!
For Neuropeptide Y (NPY) labeling, we blocked the specific sites with  10% NGS, 
0.3% Triton in PBS. Free-floating were, then, incubated overnight at 4 °C with anti-
NPY primary antibody (rabbit polyclonal, 1:5000, Peninsula), 2% NGS and 0.1% 
Triton in PBS. To reveal the primary antibody, we incubated the slices with Donkey 
anti-rabbit RRX (1:400, Jackson) with 1% NGS and 0.1% Triton in PBS. For Hoechst 
staining, slices were submerged in an aqueous solution with 3 mL of Hoechst stain 
for three minutes.!
!
!
2.6 STEREOLOGICAL QUANTIFICATION!
!
All cells were counted in blind conditions with respect to the treatment using a 
fluorescence microscope and Stereoinvestigator software (MicroBrightField): a 40x 
objective (air, 0.75 NA) was used for Dcx and Dcx/NeuN positive cells, while a 20x 
objective (air, 0.50 NA) was chosen for BrdU and NPY positive cells.!
The counting of stained cells was performed using every six sections spaced 300 %m 
apart, counting 10 to 11 sections per mouse. To investigate the number of progenitor 
cell-derived neurons, or Dcx labelled cells, every label cells within DG was counted: 
during this phase, the contour of all somas was traced.!
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Then, to clarify the numbers of immature neurons which were on the verge to 
become mature, or Dcx/NeuN positive cells, all the cells whose soma matched the 
contour previously described were counted. Eventually, the percentage between the 
total number of Dcx positive cells and Dcx/NeuN positive cells for every section was 
calculated. In order to find out the effective number of proliferating cells, or BrdU 
positive cells, all the labelled cells in the DG were counted. To analyze the number of 
inhibitory interneurons or NPY positive cells, all the stained cells in the hilus of DG 
were quantified. Finally, to investigate the morphology of the DG and hilus, a 
stereological volume measure was performed. The measure was performed by 
contouring  the DG and the hilus of every slice of each group.!
The stereological count for each label cells was performed summing all positive cells 
per animal and multiplying it for 6 (spacing factor). Finally, all representative images 
hippocampal sections were acquired with a Leica confocal microscopy using a  25x 
objective (oil, 0.75 NA) and a 40x objective (oil, 1.25 NA).!
!
2.7 STATISTICAL ANALYSIS!
!
Statistical analysis was performed using Sigmaplot 11.0 software ( Systat Software 
Inc. Chicago, IL), considering the value of significance at p = 0.05. Data normally 
distributed are summarized by mean * SEM.  T-test and one way test ANOVA were 
used for statistic analyses. We used Student’s t-test pairwise comparison of 
quantitative phenotypes between mice of different groups. Moreover, we performed 
One way test ANOVA to analyze the variance among control, sham and rescue 
group.!
!
!
 !
!
!
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3- RESULTS!
!
3.1 VOLUME OF THE DENTATE GYRUS AND HILUS OF THE 
HIPPOCAMPUS!
!
To evaluate the possible macroscopic changes in the DG morphology, a stereological 
measure of the volume of the blades and hilus of DG in Ophn-1−/y animals was 
performed. The data indicate no significant changes in Ophn-1−/y  animals with 
respect to control (Ophn-1+/y DG volume= 0.31 mm3 , hilus volume= 0.30 mm3, n= 5; 
Ophn-1−/y DG volume= 0.24 mm3, hilus volume= 0.21 mm3, n= 5. Student’s t-test, Two 
tailed p value > 0.05 fig.1a-1b).!
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Fig. 1: Morphological analysis of the DG: a) Representative images of WT and KO DG . b) Volume of the 
DG. The results show that there is no significant difference between KO and WT animals. c) Volume of the 
hilus of the DG. The data show no significant difference between KO and WT mice. Histograms represent 
mean ± SEM.!
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3.2 PROLIFERATION IN THE DENTATE GYRUS OF HIPPOCAMPUS!
!
In order to evaluate the state of proliferative cells in the DG of hippocampus in 
Ophn-1 KO mice, we used BrdU to label the mitotic cells, and the animals were 
sacrificed at 1d. To assess the number of newly generated neurons, additional 
animals were examined 15d and 50d post BrdU injection. Slices of one hemisphere 
were analyzed for each animal. Then, a stereological count was performed in order to 
identify the total number of BrdU positive cells in the DG of hippocampus. The 
results showed that no significant differences between Ophn-1−/y and Ophn-1+/y  were 
found at day 1 (Ophn-1+/y total number of cells= 1517, n= 4; Ophn-1−/y total number of 
cells= 1111, n= 4. Two tailed and one tailed p value > 0.05 fig.2a) and 15d post-
injections (Ophn-1+/y total number of cells= 1281, n=4; Ophn-1−/y total number of cells= 
968, n=3. One tailed p value <0.05; Two tailed p value > 0.05 fig.2b). Instead, 
analyzing the slices 50d post-injections, we found out that there was a strong 
decrease of BrdU positive cells in KO mice (Ophn-1+/y total number of cells= 1315, n= 
5;  Ophn-1−/y total number of cells= 648, n= 5. Mann-Whitney sum test p value < 0.05 
fig.2c). These data allow to conclude that loss of Ophn-1 has no impact on precursor 
proliferation. However, reduced numbers of BrdU-positive cells are evident in the 
long-term, likely as a result of impaired migration/maturation/network integration 
of the newborn neurons. !
!
!
!
!
!
!
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Fig.2: State of proliferative cells in the DG of hippocampus. a) Time course of the state of proliferation in the 
DG at 1d, 15d and 50d post injections: it’s clear that the decrease of BrdU positive cells is grater in Ophn-1−/y 
animals. b) c) and d) The data of BrdU positive cells in the DG, respectively at day 1, 15d and 50d post 
injections, showing that Ophn-1−/y mice, at 1d and 15d, present no differences respect to controls, indicating 
that, at this time, no impairments can be detected. Instead, at 50d post injection,there is a drastic decrease in 
Ophn-1−/y mice, evidencing that, at this point, there is a greater impairment between the two groups. 
Histograms represent mean ± SEM. e) Confocal images, showing the BrdU positive cells at 50d post 
injection. Scale bar: 100 #m. Statistical significance, *P< 0.05.
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3.3 STATE OF THE NEUROGENESIS IN THE DENTATE GYRUS OF 
HIPPOCAMPUS!
!
In order to investigate the migration and integration of newborn neurons in the DG 
of hippocampus in Ophn-1 KO mice different markers were used, to identify possible 
deficits at distinct steps of the maturation process. Therefore, Dcx positive cells and 
cells double stained cells with Dcx and NeuN were analyzed (fig.3). Moreover, thanks 
to Marco Canossa and his team, axon elongation by the newborn neurons was 
investigated.!
!
!
!
!!
 43
BrdU
P0
Proliferation
P4
Differentiation Axon formation 
P21 P28
Mature neurons
Dcx
NeuN
Fig. 3: Scheme of the timing of maturation. After the proliferative phase, at p4, the cells start their process of 
differentiation. At this point, they begin to express the Doublecortin (Dcx) protein. At p21, the maturating 
cells start forming the axon, and they begin to express the Neuron nuclear protein (NeuN). At p28, we have 
the complete formation of new neurons.
3.3.1 STATE OF THE MIGRATORY CELLS IN DENTATE GYRUS OF 
HIPPOCAMPUS!
!
To verify the state of migratory cells in DG of Ophn-1 KO mice, we used Dcx as  a 
marker. The animals were sacrificed at p75, and the brain slices of one hemisphere 
were stained with Dcx antigen. Then, a stereological analysis was performed to count 
the total number of Dcx positive cells in Ophn-1+/y and Ophn-1−/y animals. The data 
clearly indicated a substantial reduction of Dcx-positive neuroblasts in KO animals 
(Ophn-1+/y total number of cells= 7531, n=9; Ophn-1−/y total number of cells= 5144, 
n=7. One tailed and two tailed p value <0.001 fig.4).  !
!
!!
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Fig. 4: Number of migrating neuroblasts. It is evident that Ophn-1−/y animals display a reduction in Dcx-
positive cells. The confocal images report examples of Dcx labeling in KO and wt mice. Scale bar: 80 #m. 
Histograms represent mean ± SEM. Statistical significance, ***P< 0.001.!
***
!
3.3.2 AXONAL GROWTH BY NEWBORN CELLS IN THE DENTATE GYRUS OF 
HIPPOCAMPUS!
!
We are currently collaborating with Marco Canossa and his team (University of 
Bologna) to investigate axonal growth and morphological maturation of newly 
generated neurons in the hippocampus of Ophn-1 KO mice and controls. Specifically, 
this group has injected into the hippocampus retroviral vectors expressing GFP to 
label proliferating cells and has assesses axon formation at 21 days. They found that 
while about 90% of the cells in wt animals have extended an axon at 21 days, this 
percentage is dramatically reduced in KO mice (about 60%; t-test, p < 0.05) ( Ophn-1+/
y cells: with axon= 90.62%; Ophn-1−/y cells: with axon= 56.81 T-test p value < 0.05. 
Thanks to Beatrice Vignoli and Marco Canossa for the results. fig.5).!
!!!!
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Fig.5: Percentage of the cells which produce a functional axon. It’s clear that KO mice present a significant 
impairment respect to WT animals (Thanks to Beatrice Vignoli and Marco Canossa, University of Bologna).
3.3.3 STATE OF NEWBORN NEURONS IN THE DENTATE GYRUS OF 
HIPPOCAMPUS!
!
The data described in the previous sections demonstrate a reduction in the number of 
migrating neuroblasts and a deficit in axon formation by the Ophn-1 KO neurons at 
21 days after birth. Lack of the axon is predicted to impede functional integration of 
the newly generated cells, that could eventually be eliminated via programmed cell 
death. Accordingly, we quantified the total numbers of early neuronal cells (21-28 
days after birth) via Dcx-NeuN double labelling (fig.6a). The results indicate that 
Ophn-1−/y animals have a decreased number of doubled marked cells respect to the 
controls ( Ophn-1+/y total number of cells= 1161, n= 4; Ophn-1−/y total number of cells= 
678, n= 3; One tailed and two tailed test p value < 0.01 fig. 6b).!
After that, the percentage of newborn neurons cells respect to Dcx cells were 
calculated. The data shows that there is a significant decrease in the percentage of 
newborn neurons in Ophn-1−/y animals respect to Ophn-1+/y animals (Ophn-1+/y 
newborn neurons percentage = 17,34%, n= 4; Ophn-1−/y newborn neurons 
percentage= 13,44%, n= 3; One tailed and two tailed test p value < 0.001 fig. 6c). !
!!!!!!!!!!!!!
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Dcx
Fig 6: State of newborn neurons in the DG of hippocampus. a)Confocal images that report the state of 
newborn neurons: (First line: WT. Second Line: KO). Scale bars: 100 #m. b) Note the reduction in the total 
number of Dcx-NeuN double positive cells in KO mice. c) Percentage of double stained cells respect to the 
total number of Dcx cells. The results indicate a decrease of this proportion in Ophn-1−/y animals. 
Histograms represent mean ± SEM. Statistical significance, **P<0.01,***P< 0.001.!
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3.4 RESCUE OF THE PHENOTYPE VIA SYSTEMIC FASUDIL 
ADMINISTRATION!
!
We next treated a group of Ophn-1−/y mice with the ROCK inhibitor fasudil, to check 
whether pharmacological blockade of the hyperactivation of the GTPases could lead 
to a rescue of the phenotype. In particular, we investigate if fasudil rescued the 
impairments seen in total number of migrating neuroblasts (Dcx  positive cells) and 
early neuronal cells (Dcx/NeuN positive cells).!
!
3.4.1 NO RESCUE OF MIGRATION DEFECTS BY FASUDIL IN OPHN-1−/Y MICE!
!
Analyses of the total number of migrating neuroblasts in Ophn-1−/y mice treated with 
fasudil were performed, comparing the obtained results with the data seen above. 
This test showed that there was no significant difference in the rescue group with 
respect to Ophn-1−/y mice treated with water. Indeed, the total number of migrating 
neuroblasts in Ophn-1 KO mice treated with fasudil remained significantly lower 
than that of WT controls (Ophn-1+/y total number of cells= 7531, n=9; Ophn-1−/y (H2O) 
total number of cells= 5144, n=7; Ophn-1−/y (fasudil) total number of cells = 5475, n=4. 
One way test ANOVA p value < 0,001; WT vs. KO (fasudil) t-test p value < 0.05, 
KO(H2O) vs. KO(fasudil) t-test p value > 0.05 fig.7a-7b).!
!
!!!!!!!!
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!3.4.2 RESCUE OF THE EARLY NEURONAL CELLS IN OPHN-1−/Y MICE!
!
The same fasudil treatment was also used  to evaluate if fasudil could lead to a rescue 
in the population of newborn neurons and their percentage with respect to the total 
number of migrating cells (fig.8a). The data showed that there was a significant 
rescue in numbers of early neuronal cells (Dcx-NeuN double positive) in  Ophn-1−/y 
mice treated with fasudil respect to Ophn-1−/y mice treated with water (Ophn-1+/y total 
number of cells= 1161, n=4; Ophn-1−/y(H2O) total number of cells= 678, n=7; Ophn-1−/
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Fig 7: Rescue of the migratory cells phenotype. a) Confocal image showing the state of the migratory cells in 
KO mice treated with fasudil. Scale bar: 100 #m. b) The diagram shows that there is no significant increase 
in the total number of migratory cells in the rescue group respect to KO mice. Histograms represent mean ± 
SEM. Statistical significance, **P<0.05,**P< 0.01.!!
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y(fasudil) total number of cells = 930, n=4. One way test ANOVA p value < 0,001; 
Ophn-1+/y  vs. Ophn-1−/y(fasudil) t-test p value > 0.05, Ophn-1−/y(H2O) vs. Ophn-1−/y(fasudil) t-
test p value < 0.05 fig.8b.). Interestingly, the percentage of Dcx-NeuN double labelled 
cells over the total sample of Dcx-stained cells was also rescued by fasudil (Ophn-1+/y 
newborn neurons percentage= 17.34%, n= 4; Ophn-1−/y(H2O) newborn neurons 
percentage= 13.44%, n= 3; Ophn-1−/y(fasudil) newborn neurons percentage= 17.1%. One 
way test ANOVA p value < 0,001; Ophn-1+/y vs. Ophn-1−/y(fasudil) t-test p value > 0.05, 
Ophn-1−/y(H2O) vs. Ophn-1−/y(fasudil) t-test p value < 0.001 fig. 8c). !
!
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Fig. 8: Rescue of newborn neurons with fasudil. a) Confocal images showing the state of newborn neurons 
in KO mice treated with fasudil. Scale bars: 100 #m. b) Stereological count of newborn neurons, double 
marked with Dcx and NeuN. The data show a significant increase of double stained cells in Ophn-1−/y mice 
treated with fasudil. c) Percentage of newborn neurons. It’s evident that in Ophn-1−/y mice the percentage is 
similar to WT animals. Histograms represent mean ± SEM. Statistical significance, *P<0.05,***P< 0.001.!
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3.5 STATE OF NPY INHIBITORY INTERNEURONS IN THE DENTATE 
GYRUS  OF HIPPOCAMPUS!
!
According to several studies (Ring H. ACNR, 2013; Morgan C.L. et alia, Am. J. Ment. 
Retard. 2003), a significant percentage of patients with ID suffer from epilepsy. These 
data suggest an impaired excitation/inhibition ratio in Ophn-1 mice. As a first step 
towards the characterization of inhibitory neurons in ID, we stained hippocampal 
sections from wt and KO mice with an anti-NPY antibody, and  the number of NPY 
interneurons was quantified. The results indicate that Ophn-1−/y  animals  showed a 
reduced number of interneurons in the hilus of the DG respect to the Ophn-1+/y 
animals (Ophn-1+/y total number of interneurons= 1534, n=4; Ophn-1−/y  total number 
of interneurons= 1286, n=3. Two tailed p value < 0.05, one tailed p value < 0.01 fig.9).!
!!!!!!
!
 51
WT
0
200
400
600
800
1000
1200
1400
1600
 
N
py
 p
os
iti
ve
 c
el
ls
WT KO
Fig 9: State of inhibitory system in the DG of hippocampus. The data show that there is a significant impairment 
concerning the number of NPY positive cells in Ophn-1−/y mice respect to WT animals. The confocal images report 
examples of NPY labeling in KO and WT mice. Histograms represent mean ± SEM. Scale Bar: 100 #m. Statistical 
significance, *P<0.05!
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4- DISCUSSION!
!
The aim of this thesis was to investigate neurogenesis in the DG of the hippocampus 
in a mouse model of ID, caused by a loss of function in Ophn-1. Moreover, the state 
of the NPY positive inhibitory circuitry was analyzed, to verify if the loss of function 
of Ophn-1 could lead to an epileptic phenotype. !
First of all, an analysis of the macroscopic morphological changes in the DG was 
performed: the measures of the volume of blades and hilus of DG showed that loss of 
Ophn-1 does not alter dramatically the cytoarchitecture of the hippocampus. In this 
context, it is interesting to note that a more detailed analysis of pyramidal neurons 
showed alterations in dendritic architecture in Ophn-1 KO mice. Specifically, spine 
densities and spine morphology were particularly affected (Khelfaoui et al., J. 
Neurosci. 2007). At the behavioral level, hippocampus-dependent tasks such as the 
Morris water maze test were significantly impaired in the KO animals (Khelfaoui et 
al., J. Neurosci. 2007). !
Next, I focused on the neurogenesis process and analyzed every step of it, with the 
aim of detecting possible impairments in KO mice. !
To study the proliferating phase, I used BrdU as marker for mitotic cells. BrdU label 
permits to study cell proliferation in the acute phase and the subsequent survival, 
migration and integration of newborn neurons at different times. Accordingly, I 
studied BrdU labelling in wt and KO mice in acute conditions (1 day), and at 15 and 
50 days post-injection. The results indicate that the impairment is evident at P50, but 
no in the acute phase and after 15d, in Ophn-1 KO mice. These results indicate that 
loss of Rho GAP activity has no impact on cell division in the SGZ of the 
hippocampus, and indicates that later steps of neuronal differentiation are impacted.!
 !
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Newborn cells differentiate into migrating neuroblasts and migrate short distances to 
enter the DG of the hippocampus, where they become excitatory neurons and extend 
axons towards their targets in the CA3 region (Gage F.H., Science 2000). !
Thus, I studied the state of migrating cells in the DG, using Dcx as marker. The 
results show that Ophn-1 KO mice have a significant impairment with respect to WT. 
The reduced number of Dcx-positive cells in Ophn-1 KO mice may be explained by 
the important role played by Rho GTPases in cell motility. Indeed cells in motion 
need actin dynamics to attach and detach from the extracellular matrix, and these 
processes are dependent on actin polymerization and depolymerization, which are 
potently impacted by Rho GTPases and their effectors. !
In collaboration with the group of Marco Canossa in Bologna, we asked whether 
axon extension (another process potently impacted by Rho GTPases) could by 
affected by Ophn-1 deficiency. Indeed we found a robust deficit in axon formation by 
the Ophn-1 neurons. Hyperactivation of the Rho signaling pathway is one of the 
most powerful inhibitors of axon extension and regeneration, and this is in 
agreement with the present results where lack of Ophn-1 produces persistent RhoA 
activation (Khelfaoui et al., 2014). Failure to extend an axon is likely to result in lack 
of trophic support from target neurons and consequent degeneration. Thus, we could 
think that the missing development of the axon leads to apoptosis of migrating 
neuroblasts in Ophn-1 KO mice around 21-28 days after birth, i.e., the time when 
they start maturing. Indeed, staining the cells 21-28 days after birth with Dcx-NeuN 
revealed a profound loss of early neuronal cells in the KO animals. Altogether, all 
these results confirm that Ophn-1 is involved in the correct development and 
integration of the newborn hippocampal cells.!
Because the loss of function of Ophn-1 leads to an hyperactivation of the Rho 
GTPases activity, I wanted to test if the ROCK inhibitor fasudil could lead to a rescue 
of the phenotype: then, a rescue group of animals was analyzed, in particular on the 
state of the migrating cells and early neuronal cells. The results of the migrating cells, 
marked as before, show that there is a significant increase in the number of Dcx/
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NeuN positive cells in the rescue group respect to KO mice treated with water. 
Moreover, the percentage of newborn neurons respect to the total number of Dcx 
positive cells were calculated, showing that there is a rescue of the phenotype in KO 
mice treated with fasudil. All these results show that fasudil rescues the phenotype of 
ID. Fasudil has recently been proposed as a possible treatment for Ophn-1-dependent 
ID based on the positive results of a mouse study (Khelfaoui et al., Phil. Trans. R. Soc. 
B 2014). !
Finally, because recent studies showed that the ID phenotype is strictly connected to 
epilepsy, a preliminary study of the inhibitory NPY-positive circuitry was performed. 
The data show that there is a significant impairment in the state of NPY positive cells 
in Ophn-1 KO mice: thus, Ophn-1 seems involved, also, in the normal formation of 
the inhibitory circuitry. Previous data in the literature have shown that Ophn-1 mice 
have deficits in both excitatory and inhibitory synaptic transmission in the 
hippocampus (Powell et al., 2012). Interestingly, these alterations can be rescued by 
acute bath application in slices of a ROCK inhibitor (Khelfaoui et al., Hum. Molec. 
Genet. 2009). We are currently expanding our analysis of inhibitory circuitry in the 
hippocampus and I have stained sections of wt and KO animals with antibodies that 
label other GABAergic cell subsets (parvalbumin and somatostatin-positive). The 
counts of these populations are currently underway. I also plan to perform recordings 
of electrographic (EEG) activity from the hippocampus of Ophn-1 KO mice to detect 
evidence for epileptiform activity, and the possible rescue effects of fasudil treatment. !
In summary, this study demonstrates that Ophn-1 plays a major role in adult 
neurogenesis. These data are important since they suggest that specific steps of 
neuronal development such as axon extension, migration of neuroblasts, and 
integration of newborn neurons are disrupted in the embryonic brain following loss 
or mutation of Ophn-1. These alterations may be at the basis of the cognitive deficits 
observed in Ophn-1-related ID.  The deficits in adult neurogenesis could further add 
to the cognitive impairment (Gage F.H., Science 2000). However, it seems that there is 
a pharmacological way to rescue the phenotype: the ROCK inhibitor fasudil, 
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blocking signaling downstream of activated Rho, leads to a partial rescue of 
neurogenesis in KO mice. Interestingly, fasudil appears to be ineffective in correcting 
the total number of migrating neuroblasts. These data indicate that migration deficits 
are insensitive to ROCK inhibition and may thus depend on the hyperactivation of 
other Rho GTPases (such as Rac or Cdc42). !
Altogether, this study has revealed how adult neurogenesis is influenced by the loss 
of function of Ophn-1 protein, permitting to better understand not only the 
mechanisms that regulate adult neurogenesis, but also the disrupted developmental 
steps involved in the ID phenotype. Using these results as a start point, it will be 
possible to focus on more specific molecular mechanisms involved in neurogenesis 
and ID, permitting a possible way to assist the current therapies for this complex 
syndrome.!
!!!!!!!!!!!!!!!!!!!!!
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